109054 ⎘
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor; Recombinant DNA-technology; DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides against enzymes
siRNA targeting LDHA
#1502Compositions and Methods for Treating Alzheimer's Disease and Other Tauopathies
#1503Compositions and methods for treating beta-hemoglobinopathies
#1504Medicament for liver regeneration and for treatment of liver failure
#1505MEDICAMENT FOR LIVER REGENERATION AND FOR TREATMENT OF LIVER FAILURE
#1506GAMMA-SECRETASE INHIBITION REDUCE APOC3 LEVELS AND PLASMA TRIGLYCERIDES
#1507Antihelminthic medications for pathogenic nematodes
#1508TARGETING PARP1 FOR TREATMENT OF TSC AND CANCERS
#1509Bacterially-derived, intact minicells that encompass plasmid-free functional nucleic acid for in vivo delivery to mammalian cells
#1510Treatment and diagnosis of inflammatory disorders
#1511In vivo gene silencing by chemically modified and stable siRNA
#1512Amine cationic lipids and uses thereof
#1513Methods and compositions for the activation of gamma-delta T-cells
#1514Combination vectors and methods for treating cancer
#1515ANTI-TUMOR THERAPY
#1516Modulation of DYRK1B expression
#1517Methods for treating hypercholesterolemia
#1518Cancer examination method and examination kit
#1519RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)
#1520Cell Differentiation Marker and its Uses
#1521Technology for the Preparation of Microparticles
#1522ANTISENSE OLIGONUCLEOTIDES FOR MODULATING HTRA1 EXPRESSION
#1523POLYMERASE Q AS A TARGET IN HR-DEFICIENT CANCERS
#1524Gene/carrier complex for preventing or treating inflammatory diseases
#1525Double strand RNA-mediated RNA interference through feeding detrimental to larval (gypsy moth)
#1526MODULATORS OF COMPLEMENT FACTOR B
#1527Compositions and methods for genetically modifying myosin phosphatase target subunit (Mypt1) gene for lowering blood pressure
#1528Decreasing lactate level and increasing polypeptide production by down regulating the expression of lactate dehydrogenase and pyruvate dehydrogenase kinase
#1529Method of treating VEGF/VEGFR resistant prostate cancer by combining the therapy with RAC1 inhibitors
#1530MODULATORS OF KLK3 ERNA
#1531Managing Intercellular Communications
#1532RNA complexes that inhibit melanin production
#1533Compositions and methods for predicting response and resistance to CDK4/6 inhibition
#1534RNAi-Mediated Inhibition of Tumor Necrosis Factor Alpha-Related Conditions
#1535Gene vector
#1536Inhibition of oxidative stress in atrial fibrillation
#1537Compositions and methods comprising histidyl-tRNA synthetase splice variants having non-canonical biological activities
#1538Methods of treating myelodysplastic syndrome
#1539Methods to identify and treat subjects having corticosteroid-resistant inflammatory diseases
#1540Interfering RNA molecules
#1541Polynucleotide agents targeting factor XII (hageman factor) (F12) and methods of use thereof
#1542Methods and compositions for increasing the suppressive function of regulatory T-cells (Tregs)
#1543Methylene-tetrahydrofolate reductase isoform-based biomarker and method of use thereof
#1544Oligonucleotide compositions with enhanced efficiency
#1545Methods for treating brain metastases using combinations of anti-P13K and anti-mTOR agents
#1546BTK INHIBITORS FOR TREATING NEUROBLASTOMA
#1547Methods and materials for determining pain sensitivity and predicting and treating related disorders
#1548SINGLE-STRANDED NUCLEIC ACID MOLECULE INHIBITING EXPRESSION OF PRORENIN GENE OR PRORENIN RECEPTOR GENE, AND USE THEREOF
#1549Targeting WSB1 and pVHL to treat cancer
#1550RNA INTERFERENCE MEDIATED INHIBITION OF GENE EXPRESSION USING CHEMICALLY MODIFIED SHORT INTERFERING NUCLEIC ACID (siNA)
#1551Inhibition of Diacylglycerol Kinase to Augment Adoptive T cell Transfer
#1552Anti-ADAM33 oligonucleotides and related methods
#1553Methods of treating cancer by inhibition of DNA repair proteins using antisense based therapies
#1554DOUBLE-STRANDED OLIGONUCLEOTIDES
#1555CANCER TREATMENT METHODS AND COMPOSITIONS
#1556Peptides and nanoparticles for intracellular delivery of molecules
#1557IMMUNE EFFECTOR CELL THERAPIES WITH ENHANCED EFFICACY
#1558Polypeptides having beta-xylosidase activity and polynucleotides encoding same
#1559Modified nucleosides, analogs thereof and oligomeric compounds prepared therefrom
#1560Targeted sensitization of non-del(5q) malignant cells
#1561RNA interference agents for GST-π gene modulation
#1562Methods and compositions to increase somatic cell nuclear transfer (SCNT) efficiency by removing histone H3-lysine trimethylation
#1563Methods for reducing LRRK2 expression
#1564Targeted augmentation of nuclear gene output
#1565Compositions and Methods for Inhibition of Expression of Apolipoprotein C-III (APOC3) Genes
#1566Enzymatic replacement therapy and antisense therapy for pompe disease
#1567MAO inhibitors and their conjugates as therapeutics for the treatment of brain cancer
#1568ANTI-INFLUENZA VIRUS AGENT AND SCREENING METHOD FOR ANTI-INFLUENZA VIRUS AGENT
#1569Modulation of pre-MRNA using splice modulating oligonucleotides as therapeutic agents in the treatment of disease
#1570METHODS FOR DETERMINING RESISTANCE TO ANTICANCER THERAPY AND COMPOSITION USED THEREFOR
#1571INHIBITING GENE EXPRESSION WITH dsRNA
#1572Pharmaceutical composition for inhibition of cancer cell metastasis including siRNA for ribosomal protein S3
#1573AMPHOTERIC LIPOSOMES COMPRISING IMINO LIPIDS
#1574Somatic mutations in ATRX in brain cancer
#1575Methods and compositions for producing double allele knock outs
#1576METHOD FOR PREPARING RECOMBINANT PROTEINS THROUGH REDUCTION OF rnpA GENE EXPRESSION
#1577Guayule with increased rubber production and yield
#1578siRNA compositions that specifically downregulate expression of a variant of the PNPLA3 gene and methods of use thereof for treating a chronic liver disease or alcoholic liver disease (ALD)
#1579Methods and compositions for reducing immunosupression by tumor cells
#1580RNA interference in skin indications
#1581MODULATION OF AXON DEGENERATION
#1582Methods and Compositions for Selecting siRNA of Improved Functionality
#1583AGE-RELATED MACULAR DEGENERATION TREATMENT
#1584Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same
#1585Agents and methods for treating and preventing seborrheic keratosis
#1586Complex comprising RNAi molecule and N-acetylated chitosan
#1587POLYAMINATED POLYGLUTAMIC ACID-CONTAINING COMPOUNDS AND USES THEREOF FOR DELIVERING OLIGONUCLEOTIDES
#1588Methods and compositions related to T-cell activity
#1589Identification and use of target genes for control of plant parasitic nematodes
#1590Methods of treatment using antisense oligomers and conjugates targeting PCSK9
#1591Manufacture of antisense oligomers and conjugates targeting PCSK9
#1592MODULATORS OF DIACYGLYCEROL ACYLTRANSFERASE 2 (DGAT2)
#1593TREATMENT FOR CANCER METASTASIS
#1594RIG-I ligands and methods for producing them
#1595Application of PCSK9 inhibitors in the preparation of drugs for the treatment of inflammatory immune diseases
#1596Substituted thiazoles for preventing and/or treating cell or tissue necrosis
#1597Pharmaceutical composition for preventing and treating metabolic disease comprising MKRN1 expression or activity inhibitor as an active ingredient
#1598Compositions and methods for enhancing CRISPR activity by POLQ inhibition
#1599Treatment of down syndrome gene related diseases by inhibition of natural antisense transcript to a down syndrome gene
#1600Linkage modified oligomeric compounds
#1601Polypeptides having beta-xylosidase activity and polynucleotides encoding same
#1602Pharmaceutical Composition for Treating STK11-Mutation Cancer Using Cardiac Glycosides
#1603Method of preventing or treating osteoporosis by neddylation inhibitor
#1604SMALL INTERFERING RNA MODIFICATION METHOD BY COMBINING WITH ISONUCLEOSIDE MODIFICATION, TERMINAL PEPTIDE CONJUGATION AND CATIONIC LIPOSOMES, AND PREPARATION
#1605Lipids and lipid compositions for the delivery of active agents
#1606Compositions for treating heart disease by inhibiting the action of mAKAP-β
#1607Interfering RNA molecules
#1608USP30 INHIBITORS AND METHODS OF USE
#1609Methods and compositions for the specific inhibition of glycolate oxidase (HAO1) by double-stranded RNA
#1610PHARMACEUTICAL COMPOSITION FOR NEURODEGENERATIVE BRAIN DISEASE AND SCREENING METHOD FOR THE SAME
#1611Methods and compositions for the treatment of head and neck cancer
#1612Therapeutic agent for sarcopenia and metabolic diseases
#1613Compositions and methods of treating amyotrophic lateral sclerosis (ALS)
#1614Expression of Fc-containing proteins
#1615LIN28- MEDIATED CONTROL OF LET-7 BIOGENESIS
#1616Methods and compositions for treatment of atherosclerosis
#1617Genetic or pharmacological reduction of PERK enhances cortical- and hippocampus-dependent cognitive function
#1618Method for treating a degenerative neurological disorders comprising administering ASM inhibitor
#1619BIOMARKERS ASSOCIATED WITH BRM INHIBITION
#1620Renal selective inhibition of cytochrome P450 3A5
#1621Compounds for inducing anti-tumor immunity and methods thereof
#1622Conjugated antisense compounds and their use
#1623Compositions and methods for treating HIV-associated neurocognitive disorders
#1624Oligomeric compounds comprising bicyclic nucleotides and uses thereof
#1625Compositions and methods for inhibiting expression of ADAMTS-5 and ADAM17
#1626COMPOSITIONS AND METHODS FOR ENHANCED INTESTINAL ABSORPTION OF CONJUGATED OLIGOMERIC COMPOUNDS
#1627RNA INTERFERENCE MEDIATED INHIBITION OF GENE EXPRESSION USING CHEMICALLY MODIFIED SHORT INTERFERING NUCLEIC ACID (siNA)
#1628Methods and compositions of short small hairpin RNAS and microRNAS for wound healing
#1629ANTISENSE DESIGN
#1630ANTISENSE DESIGN
#1631ANTISENSE COMPOSITIONS TARGETING ERWINIA SPECIES AND METHODS OF USING THE SAME
#1632Modulation of TMPRSS6 expression
#1633COMPOSITIONS AND METHODS FOR THE MODULATION OF DNA DAMAGE RESPONSES USING BAL1 AND BBAP
#1634Fibrotic treatment
#1635Interfering RNA molecules
#1636Compositions and methods for treating leukemia
#1637SITE-SPECIFIC DELIVERY OF NUCLEIC ACIDS BY COMBINING TARGETING LIGANDS WITH ENDOSOMOLYTIC COMPONENTS
#1638Treatments of oxidative stress conditions
#1639Compositions and methods for modulating ABHD2 activity
#1640Antisense oligomers targeting PCSK9
#1641Compositions and methods for inhibiting expression of the PCSK9 gene
#1642XANTHINE DEHYDROGENASE (XDH) IRNA COMPOSITIONS AND METHODS OF USE THEREOF
#1643METHODS FOR REDUCING PROTEOTOXICITY
#1644PROCESS FOR INDUCING RESISTANCE TO DIPHTHERIA TOXIN IN HUMAN CELLS, PRODUCTS AND USES THEREOF
#1645ANTISENSE-INDUCED EXON2 INCLUSION IN ACID ALPHA-GLUCOSIDASE
#1646HSD17B13 variants and uses thereof
#1647HSD17B13 variants and uses thereof
#1648Regulatory Protein Deficient Trichoderma Cells and Methods of Use Thereof
#1649Gene therapies for neurodegenerative disorders targeting ganglioside biosynthetic pathways
#1650Methods and compositions for selecting siRNA of improved functionality
#1651SCREENING METHOD FOR SELECTED AMINO-LIPID-CONTAINING COMPOSITIONS
#1652TREATMENT OF LIPID TRANSPORT AND METABOLISM GENE RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO A LIPID TRANSPORT AND METABOLISM GENE
#1653Method of synthesis of an ionizable cationic lipid
#1654Polynucleotide agents targeting patatin-like phospholipase domain containing 3 (PNPLA3) and methods of use thereof
#1655Fidgetin-like 2 as a target to enhance wound healing
#1656Methods and compositions for selecting siRNA of improved functionality
#1657Compounds for inducing anti-tumor immunity and methods thereof
#1658Amine-containing transfection reagents and methods for making and using same
#1659Compositions and methods for inhibiting expression of RRM2 genes
#1660Glucokinase (GCK) iRNA compositions and methods of use thereof
#1661Nucleic acid molecules targeting superoxide dismutase 1 (SOD1)
#1662Compositions and methods for inhibiting gene expression of LPA
#1663Nanocarriers and their processing for diagnostics and therapeutics
#1664METHODS AND COMPOSITIONS FOR TREATING A PROPROTEIN CONVERTASE SUBTILISIN KEXIN (PCSK9) GENE-ASSOCIATED DISORDER
#1665Oligonucleotide compounds for treatment of preeclampsia and other angiogenic disorders
#1666Reduction of lipase activity in product formulations
#1667COMPOSITIONS AND METHODS FOR INHIBITING CELL PROLIFERATION
#1668MONOAMINE OXIDASE INHIBITORS AND METHODS FOR TREATMENT AND DIAGNOSIS OF PROSTATE CANCER
#1669Use of phospholipid scramblase inhibitors for modulating inflammatory immune responses
#1670Afucosylated protein, cell expressing said protein and associated methods
#1671Ionizable cationic lipid for RNA delivery
#1672Breast cancer biomarkers and methods of using same
#1673Compositions and methods for controlling vasculature
#1674MODULATION OF DYSTROPHIA MYOTONICA-PROTEIN KINASE (DMPK) EXPRESSION
#1675Compositions and methods for delivery of a polynucleotide into a plant
#1676METHOD FOR MAINTAINING INCREASED INTRACELLULAR p53 LEVEL, INDUCED BY PLATINUM-BASED ANTICANCER DRUG, AND APPLICATION THEREOF
#1677CNS TARGETING AAV VECTORS AND METHODS OF USE THEREOF
#1678Dual Targeting siRNA Agents
#1679Delivering CRISPR therapeutics with lipid nanoparticles
#1680CARBON MATERIAL DELIVERY SYSTEMS AND METHODS
#1681Dynamin 2 inhibitor for the treatment of Duchenne's muscular dystrophy
#1682Methods for treating Parkinson's disease
#1683Cell death inducing agent for cells having BRAF gene mutation, growth suppressing agent for same cells and pharmaceutical composition for therapy of diseases caused by growth defect of same cells
#1684CRISPR-related methods and compositions with governing gRNAS
#1685DYNAMIC GENOME ENGINEERING
#1686Modulation of nuclear-retained RNA
#16872′-arabino-fluorooligonucleotide N3′˜P5′ phosphoramidates: their synthesis and use
#1688Negative regulator of plant immunity against nematodes
#1689Antisense compounds targeting genes associated with cystic fibrosis
#1690RNA amidates and thioamidates for RNAi
#1691Methods and compositions for selecting siRNA of improved functionality
#1692Nucleoside-lipid compounds with pH-sensitive dialkylorthoester chains and their use for transportation or vectorization of at least one therapeutic agent
#1693Method of targeting senescent cells
#1694METHODS AND COMPOSITIONS FOR INHIBITING THE GROWTH AND/OR PROLIFERATION OF MYC-DRIVEN TUMOR CELLS
#1695MUTEINS OF THE PYRROLINE-5-CARBOXYLATE REDUCTASE 1
#1696Compounds and methods for modulating TMPRSS6 expression
#1697Therapeutic UNA oligomers and uses thereof
#1698Cationic lipid
#1699Novel linker, preparation method, and application thereof
#1700Lipid compositions
#1701Methods for enriching gene-targeted cells
#1702Modulation of pre-mRNA using splice modulating oligonucleotides as therapeutic agents in the treatment of disease
#1703RNA interference mediated inhibition of prolyl hydroxylase domain 2 (PHD2) gene expression using short interfering nucleic acid (siNA)
#1704Antisense compounds targeting leucine-rich repeat kinase 2 (LRRK2) for the treatment of parkinsons disease
#1705Polynucleotide agents targeting hydroxyacid oxidase (glycolate oxidase, HAO1) and methods of use thereof
#1706METHOD FOR TREATING TAU PROTEIN-MEDIATED DEGENERATIVE NEURONAL DISEASE
#1707TREATMENT OF EOSINOPHILIC INFLAMMATORY DISEASE
#1708NOVEL LIPID FORMULATIONS FOR NUCLEIC ACID DELIVERY
#1709TMPRSS6 iRNA COMPOSITIONS AND METHODS OF USE THEREOF
#1710Methods of treating cancer
#1711Oligonucleotide compositions with enhanced efficiency
#1712BGL7 Beta-Glucosidase and Nucleic Acids Encoding the Same
#1713Polyvalent RNA-nanoparticle compositions
#1714NOVEL LIPID FORMULATIONS FOR NUCLEIC ACID DELIVERY
#1715METHOD FOR PREDICTING RESPONSIVENESS TO PHOSPHATIDYLSERINE SYNTHASE 1 INHIBITOR
#1716Recombinant protein-based method for the delivery of silencer RNA to target the brain
#1717NOVEL LIPID FORMULATIONS FOR DELIVERY OF THERAPEUTIC AGENTS TO SOLID TUMORS
#1718Methods to Accelerate Wound Healing in Diabetic Subjects
#1719Promoter and uses thereof
#1720EML4-ALK FUSION GENE
#1721Assay for telomere length regulators
#1722KUB5/HERA AS A DETERMINANT OF SENSITIVITY TO DNA DAMAGE
#1723siRNA sequence-independent modification formats for reducing off-target phenotypic effects in RNAi, and stabilized forms thereof
#1724Methods of treating an overweight subject
#1725THERAPEUTICS AND METHODS OF TREATING FATTY LIVER DISEASE
#1726Inflammasome activation in myelodysplastic syndromes
#1727METHOD OF DIAGNOSIS, PROGNOSIS OR TREATMENT OF NEURODEGENERATIVE DISEASES
#1728Methods of treating cancer harboring hemizygous loss of TP53
#1729COMPOSITIONS AND METHODS FOR EFFICACIOUS AND SAFE DELIVERY OF SIRNA USING SPECIFIC CHITOSAN-BASED NANOCOMPLEXES
#1730Low molecular weight cyclic amine containing cationic lipids for oligonucleotide delivery
#1731Compositions and methods for inhibiting expression of the ALAS1 gene
#1732TARGETING OLIGONUCLEOTIDES AND USES THEREOF TO MODULATE GENE EXPRESSION
#1733Methods for treating aging and skin disorders using nucleic acids targeting Tyr or MMP1
#1734Delivering functional nucleic acids to mammalian cells via bacterially-derived, intact minicells
#1735Technology for the Preparation of Microparticles
#1736Screening Method For Compound Having Obesity Preventive Or Therapeutic Activity
#1737Compositions and methods for inhibiting gene expression of factor XII
#1738COMPLEMENT INHIBITION FOR IMPROVED NERVE REGENERATION
#1739Compositions and methods for regulating arterial tone
#1740Antisense conjugates for decreasing expression of DMPK
#1741Lipid Nanoparticle Compositions and Methods of Making and Methods of Using the Same
#1742FLIP - A SELECTIVE MOLECULAR TARGET OF SENESCENT CELLS
#1743Methods for the treatment of Leber congenital amaurosis
#1744Oligonucleotide compositions and methods of making the same
#1745Oligonucleotide compositions and methods of making the same
#1746INHIBITION OF PRMT5 TO TREAT MTAP-DEFICIENCY-RELATED DISEASES
#1747Compositions and methods to promote erythropoiesis
#1748METHOD OF ENHANCING MIR-185 EXPRESSION TO REDUCE LOW DENSITY LIPOPROTEIN/CHOLESTEROL ACCUMULATION IN A CELL
#1749Compounds and methods for the modulation of proteins
#1750Agents for improved delivery of nucleic acids to eukaryotic cells
#1751METHODS AND COMPOSITIONS FOR TREATING MALIGNANT TUMORS ASSOCIATED WITH KRAS MUTATION
#1752Antisense oligonucleotides for modulating HTRA1 expression
#1753Pharmaceutical composition for preventing or treating diabetic complications and screening method for preventive or therapeutic agent for diabetic complications
#1754Compositions and methods for reactivating latent immunodeficiency virus
#1755Sequence Specific and Organism Specific Antimicrobials and Related Materials and Methods
#1756INHIBITORS OF HEMOPOIETIC CELL KINASE (P-59-HCK) AND THEIR USE IN THE TREATMENT OF INFLUENZA INFECTION
#1757Use of RNAI Inhibiting PARP Activity for the Manufacture of a Medicament for the Treatment of Cancer
#1758TREATMENT OF HUTCHINSON-GILFORD PROGERIA SYNDROME AND DISEASES RELATED TO VASCULAR AGEING
#1759ADAM12 inhibitors and their use against inflammation-induced fibrosis
#1760Therapeutic compositions for breast cancer containing protein kinase D1 inhibitor
#1761Method for modifying T cell population
#1762Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same
#1763Methods and materials for treating cancer
#1764TMPRSS6 iRNA compositions and methods of use thereof
#1765USE OF RAD18 INHIBITORS IN THE TREATMENT OF TUMORS
#1766Modulation of UBE3A-ATS expression
#1767Treatment of RNASE H1 related diseases by inhibition of natural antisense transcript to RNASE H1
#1768CNS targeting AAV vectors and methods of use thereof
#1769Methods and Compositions for Selecting siRNA of Improved Functionality
#1770siRNA compositions that specifically downregulate expression of a variant of the PNPLA3 gene and methods of use thereof for treating a chronic liver disease or alcoholic liver disease (ALD)
#1771Inhibition of proline catabolism for the treatment of cancer and other therapeutic applications
#1772METHOD AND COMPOSITION FOR TARGETED DELIVERY OF THERAPEUTIC AGENTS
#1773Method for preparing recombinant proteins through reduction of rnpA gene expression
#1774METHODS FOR TREATING HYPERCHOLESTEROLEMIA
#1775Antisense design
#1776Antisense design
#1777Patatin-like phospholipase domain containing 3 (PNPLA3) iRNA compositions and methods of use thereof
#1778PIP2 AS A MARKER FOR HDL FUNCTION AND CARDIOVASCULAR DISEASE RISK
#1779Bruton's tyrosine kinase as anti-cancer drug target
#1780Cationic lipid
#1781Targeting epigenetic regulators using a bacterial delivery system
#1782Methods and compositions to increase somatic cell nuclear transfer (SCNT) efficiency by removing histone H3-lysine trimethylation
#1783ADIPOCYTE-SPECIFIC CONSTRUCTS AND METHODS FOR INHIBITING PLATELET-TYPE 12 LIPOXYGENASE EXPRESSION
#1784Methods and compositions for cell-proliferation-related disorders
#1785Oligonucleotide compositions with enhanced efficiency
#1786Factor XIa-specific aptamers
#1787Antisense oligonucleotide for splicing adjustment of mutant dopa decarboxylase gene and using method thereof
#1788Modulation of AGPAT5 expression
#1789Modulators of ACYL-COA lysocardiolipin acyltransferase 1 (ALCAT1) and uses thereof
#1790Fusarium chitin synthase gene chs3b and the use thereof
#1791Oligonucleotide sequence for use in pathway engineering
#1792Modulatory polynucleotides
#1793INCREASING ATOH1 LIFE TO DRIVE SENSORINEURAL HAIR CELL DIFFERENTIANTION
#1794Modulation of prekallikrein (PKK) expression
#1795Methods and compositions for in vivo induction of pancreatic beta cell formation
#1796Methods and compositions for the specific inhibition of glycolate oxidase (HAO1) by double-stranded RNA
#1797Therapeutic inhibition of lactate dehydrogenase and agents therefor
#1798Method for controlling obesity using minimally invasive means
#1799Compositions and methods for inhibition of HAO1 (Hydroxyacid Oxidase 1 (Glycolate Oxidase)) gene expression
#1800Method for identification of sensitivity of a patient to telomerase inhibition therapy